Heart failure is a leading cause of mortality in the UnitedStates. As a result of advances in genetic technology, a molecularbasis of heart failure is emerging.1,2 This review highlightsthe ways in which these insights are leading to new therapeutictargets in patients with acquired forms of heart failure.
Morphologic Classification of Cardiac Hypertrophy
Myocardial hypertrophy is an early milestone during the clinicalcourse of heart failure and an important risk factor for subsequentcardiac morbidity and mortality. In response to a variety ofmechanical, hemodynamic, hormonal, and pathologic stimuli, theheart adapts to increased demands for cardiac work by increasingmuscle mass . . . [Full Text of this Article]
Genetic Methods of Studying Cardiac Hypertrophy and Failure
Assays of Cardiac-Muscle Cells
Cardiac Hypertrophy and Failure in Genetically Altered Animals
Pressure Overload and Concentric Hypertrophy
Chamber Dilatation and Dilated Cardiomyopathy
Apoptosis of Cardiac Myocytes
Cardiac Function and Contractility
Conclusions
Source Information
From the University of California San Diego–Salk Institute Program in Molecular Medicine, Department of Medicine and Center for Molecular Genetics, University of California San Diego School of Medicine, La Jolla, Calif.
Address reprint requests to Dr. Chien at the Department of Medicine, 0613-C, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, or at kchien@ucsd.edu.
References
This article has been cited by other articles:
Rouf, R., Greytak, S., Wooten, E. C., Wu, J., Boltax, J., Picard, M., Svensson, E. C., Dillmann, W. H., Patten, R. D., Huggins, G. S.
(2008). Increased FOG-2 in Failing Myocardium Disrupts Thyroid Hormone-Dependent SERCA2 Gene Transcription. Circ. Res.
103: 493-501
[Abstract][Full Text]
Niizeki, T., Takeishi, Y., Kitahara, T., Arimoto, T., Ishino, M., Bilim, O., Suzuki, S., Sasaki, T., Nakajima, O., Walsh, R. A., Goto, K., Kubota, I.
(2008). Diacylglycerol kinase-{varepsilon} restores cardiac dysfunction under chronic pressure overload: a new specific regulator of G{alpha}q signaling cascade. Am. J. Physiol. Heart Circ. Physiol.
295: H245-H255
[Abstract][Full Text]
Chu, C.-H., Tzang, B.-S., Chen, L.-M., Kuo, C.-H., Cheng, Y.-C., Chen, L.-Y., Tsai, F.-J., Tsai, C.-H., Kuo, W.-W., Huang, C.-Y.
(2008). IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via G{alpha}q interaction and protein kinase C-{alpha}/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol
197: 381-390
[Abstract][Full Text]
Jeong, D., Kim, J. M., Cha, H., Oh, J. G., Park, J., Yun, S.-H., Ju, E.-S., Jeon, E.-S., Hajjar, R. J., Park, W. J.
(2008). PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling. Circ. Res.
102: 711-719
[Abstract][Full Text]
Konhilas, J. P.
(2008). What makes a dead cell attractive?. J. Appl. Physiol.
104: 573-574
[Full Text]
Ikeda, Y., Hoshijima, M., Chien, K. R.
(2008). Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure. Physiology
23: 6-16
[Abstract][Full Text]
Rodenbaugh, D. W., Wang, W., Davis, J., Edwards, T., Potter, J. D., Metzger, J. M.
(2007). Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol.
293: H1705-H1713
[Abstract][Full Text]
Chess, D. J., Lei, B., Hoit, B. D., Azimzadeh, A. M., Stanley, W. C.
(2007). Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am. J. Physiol. Heart Circ. Physiol.
293: H1853-H1860
[Abstract][Full Text]
Sarma, S., Schulze, P. C.
(2007). Exercise as a Physiologic Intervention to Counteract Hypertension: Can a Good Idea Go Bad?. Hypertension
50: 294-296
[Full Text]
Thum, T., Galuppo, P., Wolf, C., Fiedler, J., Kneitz, S., van Laake, L. W., Doevendans, P. A., Mummery, C. L., Borlak, J., Haverich, A., Gross, C., Engelhardt, S., Ertl, G., Bauersachs, J.
(2007). MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure. Circulation
116: 258-267
[Abstract][Full Text]
Sangaralingham, S J., Tse, M Y., Pang, S. C
(2007). Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. J Endocrinol
194: 143-152
[Abstract][Full Text]
Yang, D. K., Choi, B. Y., Lee, Y.-H., Kim, Y.-G., Cho, M.-C., Hong, S.-E., Kim, D. H., Hajjar, R. J., Park, W. J.
(2007). Gene profiling during regression of pressure overload-induced cardiac hypertrophy. Physiol. Genomics
30: 1-7
[Abstract][Full Text]
Julian, R. J.
(2007). The Response of the Heart and Pulmonary Arteries to Hypoxia, Pressure, and Volume. A Short Review. Poult. Sci.
86: 1006-1011
[Abstract][Full Text]
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., Liu, P. P.
(2007). Tumor Necrosis Factor-{alpha} Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State. Circulation
115: 1398-1407
[Abstract][Full Text]
Hosseinkhani, M., Hosseinkhani, H., Khademhosseini, A., Bolland, F., Kobayashi, H., Gonzalez, S. P.
(2007). Bone Morphogenetic Protein-4 Enhances Cardiomyocyte Differentiation of Cynomolgus Monkey ESCs in Knockout Serum Replacement Medium. Stem Cells
25: 571-580
[Abstract][Full Text]
Goruppi, S., Patten, R. D., Force, T., Kyriakis, J. M.
(2007). Helix-Loop-Helix Protein p8, a Transcriptional Regulator Required for Cardiomyocyte Hypertrophy and Cardiac Fibroblast Matrix Metalloprotease Induction. Mol. Cell. Biol.
27: 993-1006
[Abstract][Full Text]
Bdolah, Y., Segal, A., Tanksale, P., Karumanchi, S. A., Lecker, S. H.
(2007). Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period. Am. J. Physiol. Regul. Integr. Comp. Physiol.
292: R971-R976
[Abstract][Full Text]
Sharma, N., Okere, I. C., Duda, M. K., Chess, D. J., O'Shea, K. M., Stanley, W. C.
(2007). Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res
73: 257-268
[Abstract][Full Text]
Yamada, S., Kane, G. C., Behfar, A., Liu, X.-K., Dyer, R. B., Faustino, R. S., Miki, T., Seino, S., Terzic, A.
(2006). Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J. Physiol.
577: 1053-1065
[Abstract][Full Text]
Azakie, A., Fineman, J. R., He, Y.
(2006). Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo. J. Thorac. Cardiovasc. Surg.
132: 1262-1271
[Abstract][Full Text]
Hoshijima, M., Knoll, R., Pashmforoush, M., Chien, K. R.
(2006). Reversal of Calcium Cycling Defects in Advanced Heart Failure: Toward Molecular Therapy. J Am Coll Cardiol
48: A15-A23
[Abstract][Full Text]
Chen, H., Yong, W., Ren, S., Shen, W., He, Y., Cox, K. A., Zhu, W., Li, W., Soonpaa, M., Payne, R. M., Franco, D., Field, L. J., Rosen, V., Wang, Y., Shou, W.
(2006). Overexpression of Bone Morphogenetic Protein 10 in Myocardium Disrupts Cardiac Postnatal Hypertrophic Growth. J. Biol. Chem.
281: 27481-27491
[Abstract][Full Text]
Srivastava, D., Yu, S.
(2006). Stretching to meet needs: integrin-linked kinase and the cardiac pump. Genes Dev.
20: 2327-2331
[Full Text]
Jeong, D., Cha, H., Kim, E., Kang, M., Yang, D. K., Kim, J. M., Yoon, P. O., Oh, J. G., Bernecker, O. Y., Sakata, S., Thu, L. T., Cui, L., Lee, Y.-H., Kim, D. H., Woo, S.-H., Liao, R., Hajjar, R. J., Park, W. J.
(2006). PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility. Circ. Res.
99: 307-314
[Abstract][Full Text]
Murdoch, C. E., Zhang, M., Cave, A. C., Shah, A. M.
(2006). NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res
71: 208-215
[Abstract][Full Text]
Berry, M. F., Engler, A. J., Woo, Y. J., Pirolli, T. J., Bish, L. T., Jayasankar, V., Morine, K. J., Gardner, T. J., Discher, D. E., Sweeney, H. L.
(2006). Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol.
290: H2196-H2203
[Abstract][Full Text]
Planavila, A., Rodriguez-Calvo, R., de Arriba, A. F., Sanchez, R. M., Laguna, J. C., Merlos, M., Vazquez-Carrera, M.
(2006). Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite. Mol. Pharmacol.
69: 1174-1181
[Abstract][Full Text]
Grieve, D. J., Byrne, J. A., Siva, A., Layland, J., Johar, S., Cave, A. C., Shah, A. M.
(2006). Involvement of the Nicotinamide Adenosine Dinucleotide Phosphate Oxidase Isoform Nox2 in Cardiac Contractile Dysfunction Occurring in Response to Pressure Overload. J Am Coll Cardiol
47: 817-826
[Abstract][Full Text]
Watkins, S. J., Jonker, L., Arthur, H. M.
(2006). A direct interaction between TGF{beta} activated kinase 1 and the TGF{beta} type II receptor: Implications for TGF{beta} signalling and cardiac hypertrophy. Cardiovasc Res
69: 432-439
[Abstract][Full Text]
Arimoto, T., Takeishi, Y., Takahashi, H., Shishido, T., Niizeki, T., Koyama, Y., Shiga, R., Nozaki, N., Nakajima, O., Nishimaru, K., Abe, J.-i., Endoh, M., Walsh, R. A., Goto, K., Kubota, I.
(2006). Cardiac-Specific Overexpression of Diacylglycerol Kinase {zeta} Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice. Circulation
113: 60-66
[Abstract][Full Text]
Liu, X., Li, T., Sun, S., Xu, F., Wang, Y.
(2006). Role of myofibrillogenesis regulator-1 in myocardial hypertrophy. Am. J. Physiol. Heart Circ. Physiol.
290: H279-H285
[Abstract][Full Text]
Joza, N., Oudit, G. Y., Brown, D., Benit, P., Kassiri, Z., Vahsen, N., Benoit, L., Patel, M. M., Nowikovsky, K., Vassault, A., Backx, P. H., Wada, T., Kroemer, G., Rustin, P., Penninger, J. M.
(2005). Muscle-Specific Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy. Mol. Cell. Biol.
25: 10261-10272
[Abstract][Full Text]
Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., Cantley, L. C.
(2005). Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy. Mol. Cell. Biol.
25: 9491-9502
[Abstract][Full Text]
Wang, J., Xu, N., Feng, X., Hou, N., Zhang, J., Cheng, X., Chen, Y., Zhang, Y., Yang, X.
(2005). Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure. Circ. Res.
97: 821-828
[Abstract][Full Text]
Wettschureck, N., Offermanns, S.
(2005). Mammalian G Proteins and Their Cell Type Specific Functions. Physiol. Rev.
85: 1159-1204
[Abstract][Full Text]
Shapiro, J. I.
(2005). Potassium Depletion and Cardiac Hypertrophy: How Does It Work?. Hypertension
46: 477-478
[Full Text]
Duan, S. Z., Ivashchenko, C. Y., Russell, M. W., Milstone, D. S., Mortensen, R. M.
(2005). Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator-Activated Receptor-{gamma} Both Induce Cardiac Hypertrophy in Mice. Circ. Res.
97: 372-379
[Abstract][Full Text]
Cunha-Neto, E., Dzau, V. J., Allen, P. D., Stamatiou, D., Benvenutti, L., Higuchi, M. L., Koyama, N. S., Silva, J. S., Kalil, J., Liew, C.-C.
(2005). Cardiac Gene Expression Profiling Provides Evidence for Cytokinopathy as a Molecular Mechanism in Chagas' Disease Cardiomyopathy. Am. J. Pathol.
167: 305-313
[Abstract][Full Text]
Gao, X.-M., Kiriazis, H., Moore, X.-L., Feng, X.-H., Sheppard, K., Dart, A., Du, X.-J.
(2005). Regression of pressure overload-induced left ventricular hypertrophy in mice. Am. J. Physiol. Heart Circ. Physiol.
288: H2702-H2707
[Abstract][Full Text]
Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D., Lecker, S., Taegtmeyer, H., Goldberg, A. L., Walsh, K.
(2005). The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling. J. Biol. Chem.
280: 20814-20823
[Abstract][Full Text]
De Acetis, M., Notte, A., Accornero, F., Selvetella, G., Brancaccio, M., Vecchione, C., Sbroggio, M., Collino, F., Pacchioni, B., Lanfranchi, G., Aretini, A., Ferretti, R., Maffei, A., Altruda, F., Silengo, L., Tarone, G., Lembo, G.
(2005). Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload. Circ. Res.
96: 1087-1094
[Abstract][Full Text]
Coles, J. G., Boscarino, C., Takahashi, M., Grant, D., Chang, A., Ritter, J., Dai, X., Du, C., Musso, G., Yamabi, H., Goncalves, J., Kumar, A. S., Woodgett, J., Lu, H., Hannigan, G.
(2005). Cardioprotective stress response in the human fetal heart. J. Thorac. Cardiovasc. Surg.
129: 1128-1136
[Abstract][Full Text]
Casey, T. M., Arthur, P. G., Bogoyevitch, M. A.
(2005). Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro. Mol. Cell. Proteomics
4: 651-661
[Abstract][Full Text]
Nakamura, T., Matsumoto, K., Mizuno, S., Sawa, Y., Matsuda, H., Nakamura, T.
(2005). Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am. J. Physiol. Heart Circ. Physiol.
288: H2131-H2139
[Abstract][Full Text]
Klotz, S., Barbone, A., Reiken, S., Holmes, J. W., Naka, Y., Oz, M. C., Marks, A. R., Burkhoff, D.
(2005). Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol
45: 668-676
[Abstract][Full Text]
Tsoporis, J. N., Marks, A., Haddad, A., Dawood, F., Liu, P. P., Parker, T. G.
(2005). S100B Expression Modulates Left Ventricular Remodeling After Myocardial Infarction in Mice. Circulation
111: 598-606
[Abstract][Full Text]
Ricci, R., Eriksson, U., Oudit, G. Y., Eferl, R., Akhmedov, A., Sumara, I., Sumara, G., Kassiri, Z., David, J.-P., Bakiri, L., Sasse, B., Idarraga, M.-H., Rath, M., Kurz, D., Theussl, H.-C., Perriard, J.-C., Backx, P., Penninger, J. M., Wagner, E. F.
(2005). Distinct functions of junD in cardiac hypertrophy and heart failure. Genes Dev.
19: 208-213
[Abstract][Full Text]
Arya, R., Kedar, V., Hwang, J. R., McDonough, H., Li, H.-H., Taylor, J., Patterson, C.
(2004). Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J. Cell Biol.
167: 1147-1159
[Abstract][Full Text]
Xie, Z., Singh, M., Singh, K.
(2004). Osteopontin Modulates Myocardial Hypertrophy in Response to Chronic Pressure Overload in Mice. Hypertension
44: 826-831
[Abstract][Full Text]
Dixon, I. M.C., Drobic, V.
(2004). Gender Dependency in the Pathogenesis of Cardiac Hypertrophy: Effect of Norepinephrine on Transforming Growth Factor-{beta} Release in Female Heart. Hypertension
44: 392-393
[Full Text]
Khanna, S., Cheng, G., Gong, B., Mustari, M. J., Porter, J. D.
(2004). Genome-Wide Transcriptional Profiles Are Consistent with Functional Specialization of the Extraocular Muscle Layers. IOVS
45: 3055-3066
[Abstract][Full Text]
Fiedler, B., Wollert, K. C
(2004). Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res
63: 450-457
[Abstract][Full Text]
Kardami, E., Jiang, Z.-S., Jimenez, S. K, Hirst, C. J, Sheikh, F., Zahradka, P., Cattini, P. A
(2004). Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc Res
63: 458-466
[Abstract][Full Text]
van Empel, V. P.M, De Windt, L. J
(2004). Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res
63: 487-499
[Abstract][Full Text]
Coronella-Wood, J., Terrand, J., Sun, H., Chen, Q. M.
(2004). c-Fos Phosphorylation Induced by H2O2 Prevents Proteasomal Degradation of c-Fos in Cardiomyocytes. J. Biol. Chem.
279: 33567-33574
[Abstract][Full Text]
Hirsch, J. C., Borton, A. R., Albayya, F. P., Russell, M. W., Ohye, R. G., Metzger, J. M.
(2004). Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol.
286: H2314-H2321
[Abstract][Full Text]
Conti, M., Renaud, I. M., Poirier, B., Michel, O., Belair, M.-F., Mandet, C., Bruneval, P., Myara, I., Chevalier, J.
(2004). High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.
286: R793-R800
[Abstract][Full Text]
Ibarra, C., Estrada, M., Carrasco, L., Chiong, M., Liberona, J. L., Cardenas, C., Diaz-Araya, G., Jaimovich, E., Lavandero, S.
(2004). Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes. J. Biol. Chem.
279: 7554-7565
[Abstract][Full Text]
Shohet, R. V., Kisanuki, Y. Y., Zhao, X.-S., Siddiquee, Z., Franco, F., Yanagisawa, M.
(2004). Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc. Natl. Acad. Sci. USA
101: 2088-2093
[Abstract][Full Text]
Colao, A., Ferone, D., Marzullo, P., Lombardi, G.
(2004). Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. Endocr. Rev.
25: 102-152
[Abstract][Full Text]
Jortani, S. A., Prabhu, S. D., Valdes, R. Jr
(2004). Strategies for Developing Biomarkers of Heart Failure. Clin. Chem.
50: 265-278
[Abstract][Full Text]
Babiker, F. A., De Windt, L. J., van Eickels, M., Thijssen, V., Bronsaer, R. J.P., Grohe, C., van Bilsen, M., Doevendans, P. A.
(2004). 17{beta}-Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway. Circulation
109: 269-276
[Abstract][Full Text]
Kulkarni, P. A., Sano, M., Schneider, M. D.
(2004). Phosphorylation of RNA Polymerase II in Cardiac Hypertrophy: Cell Enlargement Signals Converge on Cyclin T/Cdk9. Recent Prog Horm Res
59: 125-139
[Abstract][Full Text]
Izumiya, Y., Kim, S., Izumi, Y., Yoshida, K., Yoshiyama, M., Matsuzawa, A., Ichijo, H., Iwao, H.
(2003). Apoptosis Signal-Regulating Kinase 1 Plays a Pivotal Role in Angiotensin II-Induced Cardiac Hypertrophy and Remodeling. Circ. Res.
93: 874-883
[Abstract][Full Text]
Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., Steinberg, S. F., Backx, P. H., Penninger, J. M.
(2003). Phosphoinositide 3-Kinase {gamma}-Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure. Circulation
108: 2147-2152
[Abstract][Full Text]
Howes, A. L., Arthur, J. F., Zhang, T., Miyamoto, S., Adams, J. W., Dorn II, G. W., Woodcock, E. A., Brown, J. H.
(2003). Akt-mediated Cardiomyocyte Survival Pathways Are Compromised by G{alpha}q-induced Phosphoinositide 4,5-Bisphosphate Depletion. J. Biol. Chem.
278: 40343-40351
[Abstract][Full Text]
Spinelli, L., Petretta, M., Verderame, G., Carbone, G., Venetucci, A. A., Petretta, A., Acampa, W., Bonaduce, D., Colao, A., Cuocolo, A.
(2003). Left Ventricular Diastolic Function and Cardiac Performance during Exercise in Patients with Acromegaly. J. Clin. Endocrinol. Metab.
88: 4105-4109
[Abstract][Full Text]
Guazzi, M.
(2003). Alveolar-Capillary Membrane Dysfunction in Heart Failure: Evidence of a Pathophysiologic Role. Chest
124: 1090-1102
[Abstract][Full Text]
Gonzalez, A., Fortuno, M. A, Querejeta, R., Ravassa, S., Lopez, B., Lopez, N., Diez, J.
(2003). Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res
59: 549-562
[Abstract][Full Text]
Olson, E. N., Schneider, M. D.
(2003). Sizing up the heart: development redux in disease. Genes Dev.
17: 1937-1956
[Full Text]
Grzeskowiak, R., Witt, H., Drungowski, M., Thermann, R., Hennig, S., Perrot, A., Osterziel, K. J., Klingbiel, D., Scheid, S., Spang, R., Lehrach, H., Ruiz, P.
(2003). Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res
59: 400-411
[Abstract][Full Text]
Koga, A., Oka, N., Kikuchi, T., Miyazaki, H., Kato, S., Imaizumi, T.
(2003). Adenovirus-Mediated Overexpression of Caveolin-3 Inhibits Rat Cardiomyocyte Hypertrophy. Hypertension
42: 213-219
[Abstract][Full Text]
Ancey, C., Menet, E., Corbi, P., Fredj, S., Garcia, M., Rucker-Martin, C., Bescond, J., Morel, F., Wijdenes, J., Lecron, J.-C., Potreau, D.
(2003). Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovasc Res
59: 78-85
[Abstract][Full Text]
Henning, R. J., Li, Y.
(2003). Cocaine Produces Cardiac Hypertrophy by Protein Kinase C Dependent Mechanisms. J CARDIOVASC PHARMACOL THER
8: 149-160
[Abstract]
Hon, J. K. F., Yacoub, M. H.
(2003). Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann. Thorac. Surg.
75: S36-41
[Abstract][Full Text]
Fortuno, M. A., Gonzalez, A., Ravassa, S., Lopez, B., Diez, J.
(2003). Clinical implications of apoptosis in hypertensive heart disease. Am. J. Physiol. Heart Circ. Physiol.
284: H1495-H1506
[Full Text]
Burkhoff, D.
(2003). New heart failure therapy: The shape of things to come?. J. Thorac. Cardiovasc. Surg.
125: S50-52
[Full Text]
Podewski, E. K., Hilfiker-Kleiner, D., Hilfiker, A., Morawietz, H., Lichtenberg, A., Wollert, K. C., Drexler, H.
(2003). Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy. Circulation
107: 798-802
[Abstract][Full Text]
Wang, X., Ren, B., Liu, S., Sentex, E., Tappia, P. S., Dhalla, N. S.
(2003). Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J. Appl. Physiol.
94: 752-763
[Abstract][Full Text]
Pikkarainen, S., Tokola, H., Kerkela, R., Majalahti-Palviainen, T., Vuolteenaho, O., Ruskoaho, H.
(2003). Endothelin-1-specific Activation of B-type Natriuretic Peptide Gene via p38 Mitogen-activated Protein Kinase and Nuclear ETS Factors. J. Biol. Chem.
278: 3969-3975
[Abstract][Full Text]
Steenman, M., Chen, Y.-W., Le Cunff, M., Lamirault, G., Varro, A., Hoffman, E., Leger, J. J.
(2003). Transcriptomal analysis of failing and nonfailing human hearts. Physiol. Genomics
12: 97-112
[Abstract][Full Text]
van Rooij, E., Doevendans, P. A., de Theije, C. C., Babiker, F. A., Molkentin, J. D., De Windt, L. J.
(2002). Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy. J. Biol. Chem.
277: 48617-48626
[Abstract][Full Text]
BEHFAR, A., ZINGMAN, L. V., HODGSON, D. M., RAUZIER, J.-M., KANE, G. C., TERZIC, A., PUCEAT, M.
(2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB J.
16: 1558-1566
[Abstract][Full Text]
Chaqour, B., Whitbeck, C., Han, J.-S., Macarak, E., Horan, P., Chichester, P., Levin, R.
(2002). Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am. J. Physiol. Endocrinol. Metab.
283: E765-E774
[Abstract][Full Text]
Erami, C., Zhang, H., Ho, J. G., French, D. M., Faber, J. E.
(2002). alpha 1-Adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am. J. Physiol. Heart Circ. Physiol.
283: H1577-H1587
[Abstract][Full Text]
Fiedler, B., Lohmann, S. M., Smolenski, A., Linnemuller, S., Pieske, B., Schroder, F., Molkentin, J. D., Drexler, H., Wollert, K. C.
(2002). Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc. Natl. Acad. Sci. USA
99: 11363-11368
[Abstract][Full Text]
Black, R. G. Jr, Guo, Y., Ge, Z.-D., Murphree, S. S., Prabhu, S. D., Jones, W. K., Bolli, R., Auchampach, J. A.
(2002). Gene Dosage-Dependent Effects of Cardiac-Specific Overexpression of the A3 Adenosine Receptor. Circ. Res.
91: 165-172
[Abstract][Full Text]
Ozcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hubner, N., Chien, K. R., Birchmeier, C., Garratt, A. N.
(2002). Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc. Natl. Acad. Sci. USA
99: 8880-8885
[Abstract][Full Text]
Park, D. S., Woodman, S. E., Schubert, W., Cohen, A. W., Frank, P. G., Chandra, M., Shirani, J., Razani, B., Tang, B., Jelicks, L. A., Factor, S. M., Weiss, L. M., Tanowitz, H. B., Lisanti, M. P.
(2002). Caveolin-1/3 Double-Knockout Mice Are Viable, but Lack Both Muscle and Non-Muscle Caveolae, and Develop a Severe Cardiomyopathic Phenotype. Am. J. Pathol.
160: 2207-2217
[Abstract][Full Text]
Briest, W.
(2002). Do we have a new early marker of chronic transplant dysfunction now?. Cardiovasc Res
54: 492-494
[Full Text]
Hardt, S. E., Sadoshima, J.
(2002). Glycogen Synthase Kinase-3{beta}: A Novel Regulator of Cardiac Hypertrophy and Development. Circ. Res.
90: 1055-1063
[Abstract][Full Text]
Raidel, S. M., Haase, C., Jansen, N. R., Russ, R. B., Sutliff, R. L., Velsor, L. W., Day, B. J., Hoit, B. D., Samarel, A. M., Lewis, W.
(2002). Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am. J. Physiol. Heart Circ. Physiol.
282: H1672-H1678
[Abstract][Full Text]
Young, M. E., McNulty, P., Taegtmeyer, H.
(2002). Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms. Circulation
105: 1861-1870
[Full Text]
Frey, N., Olson, E. N.
(2002). Modulating Cardiac Hypertrophy by Manipulating Myocardial Lipid Metabolism?. Circulation
105: 1152-1154
[Full Text]
Adamopoulos, S., Parissis, J., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Coats, A. J. S., Kremastinos, D. T.
(2002). Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure. J Am Coll Cardiol
39: 653-663
[Abstract][Full Text]
Peterson, K. L.
(2002). Pressure overload hypertrophy and congestive heart failure: Where is the "Achilles' heel"?. J Am Coll Cardiol
39: 672-675
[Full Text]
Liu, Z.-P., Olson, E. N.
(2002). Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc. Natl. Acad. Sci. USA
99: 2043-2048
[Abstract][Full Text]
Levin, A.
(2002). The role of anaemia in the genesis of cardiac abnormalities in patients with chronic kidney disease. Nephrol Dial Transplant
17: 207-210
[Full Text]
Previous
